Background: Testicular cancer incidence peaks during the third decade of life, and an increasing trend in the occurrence of this disease has been seen in many countries. Few risk factors have been established for testicular cancer, but evidence suggests that causal factors operate early in life, perhaps even in utero. Purpose: We performed a case-control study to evaluate specific perinatal characteristics as risk factors for the two main histopathologic types of testicular cancer: seminomas and nonseminomas. Methods: Two hundred thirty-two case patients with invasive testicular cancer and 904 individually matched control subjects (all singleton births), nested in a cohort of men born at 10 hospitals in Sweden from 1920 through 1978, were included in the study. Perinatal information about the study subjects and their parents was obtained from birth records. For the mothers, information was recorded concerning age at menarche, marital status, parity, age at delivery, maternal weight at delivery and at first visit to a maternal-care center, education and/or profession, and any medical problems encountered during pregnancy or after delivery. For the fathers, information was obtained concerning age at delivery and education and/or profession. For the study subjects, information was recorded about the following: gestational age, birth length and weight, placental weight, method of delivery (normal, cesarean section, or with forceps or vacuum extractor), medical problems during hospital stay, presence of jaundice, method of feeding at discharge, and duration of hospital stay after birth. Individuals diagnosed with testicular cancer were identified through the Swedish National Cancer Registry and the Uppsala Regional Cancer Registry. The data were analyzed by use of conditional logistic regression modeling. Results: When testicular cancer was modeled as a single entity, significantly elevated risks were associated with neonatal jaundice (adjusted odds ratio [OR] = 2 JO; 95% confidence interval [CI] = 1.07-4.94) and with either low (<2500 g) or high (>4000 g) birth weight (OR = 2.59; 95% CI = 1.05-6.38 and OR = 1.58; 95% CI = 1.10-2.29, respectively). When seminomas and nonseminomas were analyzed separately, high maternal socioeconomic status (OR = 2.54; 95% CI = 1.05-6.12), neonatal jaundice
surrogate measures of estrogen levels during gestation. Low birth weight, high maternal weight, low birth order, high social class, high maternal age, nausea, and bleeding or spotting during pregnancy have been associated with increased risk {420, . However, the results from these relatively few analyses are inconsistent, possibly because of low statistical power and difficulties in obtaining reliable information on actual hormonal exposures. Furthermore, few studies have attempted to distinguish seminomas from nonseminomatous germ cell tumors (nonseminomas), and none has attempted to distinguish these tumor types in relation to a large set of perinatal characteristics recorded before the occurrence of the disease.
Sweden provides unusual opportunities to assess, in an unbiased way, the risk implications of perinatal characteristics, i.e., birth weight, birth length, birth order, placental weight, and pregnancy or delivery complications (including pre-eclampsia/ eclampsia and neonatal jaundice), because these characteristics have been regularly recorded. By linking readily available hospital records with testicular cancer case patients, identified through the nationwide cancer registration system, we were able to undertake a nested case-control study of perinatal characteristics and the risk of testicular cancer (classified as seminomas and nonseminomas) within a well-defined cohort.
Subjects and Methods

Settings
This was a case-control study nested in a cohort of men delivered at 10 hospitals in Sweden from 1920 through 1978. In Sweden, all citizens have equal access to health care, and only in unusual emergencies does a pregnant woman contact a hospital outside her own county of residence. Because there is no private inpatient treatment, hospital medical services are, as a rule, population based.
Our study population consisted of aJl men bom at 10 hospitals in the Uppsala-Orebro Health Care Region from 1920 and onwards who survived at least until January I, 1958, when the Swedish Cancer Registry was established. In the early 20th century, many women had home deliveries; however, by the 1940s, most births took place in a hospital.
Since January I, 1947, all inhabitants of Sweden have been assigned a 10-digit national registration number (NRN), which is a unique personal identifier (30) . The NRN contains information about an individual's date of birth, as well as about the county of residence in 1947 or the county of birth for those bom in 1947 or after. The NRN provides correct information about the county of birth for 87.5% of all individuals born before 1947 (31) . A special code was used for immigrants until the early 1970s; thereafter, this special code was replaced by the code of the county of first residence in Sweden. In this study, underascertainment of cases could occur only for individuals who moved out of their county of birth before 1947 and were later diagnosed with testicular cancer.
All newly diagnosed malignant tumors in Sweden must be reported to the National Cancer Registry, by both the physician who makes the diagnosis and the pathologist or the cytologist who confirms it. All patients are entered in the Cancer Registry by use of their NRN. At the time of this study. National Registry information was complete through 1991.
Potentially eligible cases were all men listed in the National Cancer Registry (1958 through 1991) and in the Uppsala Regional Cancer Registry (1992 through 1994) who had been diagnosed with invasive testicular cancer (International Classification of Diseases. 7th Revision, code 178) and had the code for any of the six counties in the Uppsala-Orebro Health Care Region in their NRN. The National and Regional Cancer Registries also contain information concerning the two major histopathologic types of testicular cancer, i.e.. seminomas and nonseminomas. Nonseminomas include tumors of mixed histopathologic morphology. Through records in the parish of residence at the time of diagnosis, we were able to establish each case patient's place of birth and his family name at birth.
We identified 10 hospitals with similar systems for storing maternity charts (Avesta, Eskilstuna, Falun, Karistad, Ludvika, Mora, Orebro. Sundsvall, Uppsala, and Vasteras). The maternity wards at the various hospitals began to operate or started to use maternity charts at different times, ranging from 1874 in Uppsala to 1955 in Orebro. Potential case patients who were born at other hospitals during the study period were excluded.
There were 246 eligible case patients. Seven individuals who were delivered during twin births were excluded from further analysis because twin membership is positively associated with eclampsia and birth order and inversely associated with gestational age and birth weight. In addition, there were too few twins to allow for effective control of complex confounding influences. Furthermore, because of concern that testicular cancers diagnosed before puberty and at an old age belong to different biologic domains, the analysis was restricted to case patients diagnosed with testicular cancer after the age of 15 years and before the age of 55 years, thus excluding an additional seven cases. Therefore, 232 case patients remained for analysis.
The first four singleton male offspring bom after a case patient at the same hospital were selected as potential control subjects. To verify that a potential control subject was alive and had not been diagnosed with testicular cancer at the time the corresponding case patient was diagnosed, we examined records at the parish of residence and, on the basis of NRN, at the Swedish Death Registry, the Swedish Cancer Registry, and the Regional Cancer Registry in Uppsala. Twenty-four potential control subjects were excluded on the basis of these considerations, leaving 904 to be included in the analysis.
Data Collection
Since 1973, a standardized chart has been used at all maternity wards in Sweden to record information about newboms and their parents. For the mother, information about age at menarche, marital status, parity, age at delivery, maternal weight at the time of delivery and at the first matemal-care center visit, education and/or profession, and any medical problems encountered during pregnancy or after delivery (such as pre-eclampsia, proteinuna, hypertension, diabetes mellitus, nausea, etc.) is recorded. For the father, information about age at the time of delivery and about education and/or profession is obtained. For the child, the following information is recorded: singleton or twin, gestational age, birth length and weight, placental weight, method of delivery (normal, cesarean section, or with forceps or vacuum extractor), medical problems during hospital stay, presence of jaundice, method of feeding at discharge, and duration of hospital stay after birth.
Before 1973, the 10 maternity wards used nonstandardized charts, with varying amounts of information having been collected over different periods of time. At one extreme is Uppsala University Hospital, where all of the information described above has been recorded since 1924 (with the exception of maternal weight, which has been recorded since 1942). Other hospitals began to collect information later and, originally, covered fewer variables. Prior to 1973, information regarding placental weight was recorded only at Uppsala.
We evaluated parental socioeconomic status according to the father's or single mother's education level by use of the following categories: high (college education), medium (white-collar worker or farm owner with no college education), and low (blue-collar worker or farmhand). Maternity charts were filled out meticulously by midwives and nurses: there were few instances of missing information once a specific variable was included in the charts.
Statistical Methods
Statistical analysis was performed by modeling the data through conditional logistic regression (32) . Separate analyses were conducted for all cases of testicular cancer (232 case patients and 904 individually matched control subjects), all seminomas (107 case patients and 411 individually matched control subjects), and all nonseminomas (125 case patients and 493 individually matched control subjects). Only variables considered to be biologically plausible risk indicators, and for which there were sufficient numbers, were included in the analyses. Subjects with missing information for a particular variable were excluded from all analyses that evaluated or adjusted for that variable. If a case patient had missing information for a variable, the matched set (case patient and control subjects) was excluded from the related analyses (32) . All P values were derived from two-tailed tests; statistical significance was set at .05.
Results Table 1 shows the distribution of case patients with testicular cancer, by histologic type, and the individually matched control subjects according to maternal variables, gestational age, birth weight, birth length, placental weight, body mass index (weight in kilograms divided by the cube of the length in meters), and the occurrence of neonatal jaundice. There were fewer case patients and control subjects available for evaluation of the influence of placental weight because information about placental weight was not included in the maternity records of all participating hospitals for the entire study period. Table 2 presents conditional logistic regression-derived crude and mutually adjusted odds ratios (ORs) plus 95% confidence intervals (CIs) for testicular cancer as a single entity according to the predictor variables under study. We found significantly *The total number of case patients in the all testicular cancer and nonseminoma categories for maternal age do not sum to 232 and 125, respectively, because information on maternal age was missing for one mother.
tBody mass index = weight in kilograms divided by the cube of the length in meters. elevated ORs among newboms with neonatal jaundice (OR = 2.30; 95% CI = 1.07^.94) and infants with low (<25OO g) or high (£4000 g) birth weight (OR = 2.59; 95% CI = 1.05-6.38 and OR = 1.58; 95% CI = 1.10-2.29, respectively). Two case patients, both with nonseminomas, but no control subjects, were diagnosed with cryptorchidism in the maternity ward. Six case patients (2.6% of the total) and 14 control subjects (1.5% of the total) were delivered by use of either forceps or a vacuum extractor. Of the six case patients, four were later diagnosed with testicular nonseminomas, and two were diagnosed with seminomas. Two case patients (0.9% of the total), both diagnosed with nonseminomas, and nine control subjects (1.0% of the total) were delivered by cesarean section. Table 3 shows data for the two major histologic types of testicular cancer, i.e., seminomas and nonseminomas, separately. There were no overall striking or statistically significant differences in the risk profiles of the two histologic types ( Table 4) . The ORs increased with maternal age for seminomas and decreased for nonseminomas (Table 3) . However, neither of these trends achieved statistical significance, nor was the interaction term significant (P = .054) ( Table 4 ). The OR for nonseminomas was elevated more than twofold among the offspring of women of high socioeconomic status (OR = 2.54; 95% CI = 1.05-6.12) (Table 3) ; there was no such evidence with respect to seminomas, but the interaction term was not statistically significant (P = .34) ( Table 4) . Neonatal jaundice and low birth weight (<25OO g) were associated with significant elevations of risk for nonseminomas, the respective ORs being 3.96 (95% CI = 1.47-10.69) and 7.62 (95% CI = 1.59-36.60) ( Table 3 ); no such evidence was present for seminomas, but the interaction terms were again not statistically significant (P = .07 and P = .11, respectively) ( Table 4) . On the other hand, nonsignificantly elevated risks of developing either of the two histologic types were found among newboms with high birth weights (OR = 1.70; 95% CI = 0.97-2.96 for seminomas and OR = 1.36; 95% CI = 0.95-2.59 for nonseminomas). Placental weight was significantly associated with an increased risk of seminomas (OR = 3.50; 95% CI = 0.97-12.62; P = .05), but information about this characteristic was available for only 30% of the study subjects. A statistically significant positive association was found with nonseminomas in one category of gestational age (36-38 weeks; OR = 2.36; 95% CI = 1.28-4.33); however, this finding might be due to chance and needs careful interpretation because of a lack of consistency and trend. Although we had limited power to as- .87 *Crude ORs were from conditional logistic regression modeling that adjusted inherently for age, birth date, and place of birth. Adjusted ORs were from a model that included the variables shown up to birth weight. tReferent group for variable. Presence versus absence. §Birth length and placental weight were introduced into the model as alternatives to birth weight. .
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•"Chi" is the square root of the chi-squared statistic with one degree of freedom and has a standard normal distribution.
tBody mass index = weight in kilograms divided by the cube of the length in meters.
sess the possible role of pre-eclampsia, the risk of both testicular seminomas and nonseminomas appeared, if anything, to be inversely related to this condition.
Discussion
In this nested case-control study of testicular cancer in a well-defined cohort of patients, selection bias and information bias are almost inconceivable. Hence, the validity of a cohort study is preserved, although the statistical power is somewhat lower. The data strongly suggest that intrauterine and/or perinatal exposures may influence the risk of testicular cancer.
A possible role of estrogens in the promotion of testicular cancer, in general, has been proposed (21J23), and this hypothesis has been supported by animal studies (22) . We did not find any statistically significant differences in risk of the two major histologic types of this disease associated with the perinatal characteristics studied (see heterogeneity test results in Table 4 ), and any hypothesis concerning etiologic differences based on our results must, therefore, be tentative. However, in our study, it appeared that indicators of higher levels of pregnancy estrogens, such as higher maternal age (33) , high placental weight (26) , and low parity (33 J4) , imparted an increased risk mostly of seminomas. Exposures associated with intrauterine growth retardation, such as low birth weight and younger maternal age, appeared to increase the risk mostly of nonseminomas.
In most earlier analytic epidemiologic studies, testicular cancer has been treated as a single entity, primarily because the descriptive epidemiology of the two major histologic types is similar and because of numerical constraints. Therefore, a comparison of our findings with those of previous studies is difficult to perform. In our study, we found a somewhat decreased risk of seminoma with higher parity (Table 3 ). This finding is consistent with the results of a Danish study (27) . Furthermore, in another study (28) , low parity and high maternal age were positively associated with the risk of seminoma. An increased risk of testicular cancer with increasing socioeconomic status has also been reported (429); however, in our study, the excess risk was confined to nonseminomas.
We found that neonatal jaundice was significantly associated with an increased risk of testicular nonseminoma, an association previously indicated for cryptorchidism (55), but, to our knowledge, never before associated with testicular cancer. The lack of information on cryptorchidism in our study population is certainly a weakness, but it is unlikely to have major confounding implications unless unrealistic assumptions are invoked. The prevalence of cryptorchidism among patients with testicular cancer is 5%-10% (13), and variables with low prevalence have limited confounding potential (36) . The association of neonatal jaundice with nonseminoma was even more pronounced after adjusting for prematurity and low birth weight. Although it is likely that these results are a consequence of colinearity between the variables, it should be noted that catabolites of hemoglobin have been reported to act as cancer-initiating agents (37) . Also, there are other conceivable explanations. A frequent cause of neonatal jaundice is blood incompatibility between the mother and the child; however, in our data, nonseminoma with or without neonatal jaundice was not associated with high parity, a pattern that should exist if this was the underlying mechanism. Prolonged labor can also result in neonatal jaundice, through hematomas induced by the use of forceps or vacuum extractors. Moreover, jaundice can be a clinical sign of intrauterine or perinatal infection (38) . Viral infections have been proposed to cause testicular cancer by several investigators (19 J9) , but the role of such infections remains controversial.
The placenta is the main hormone-producing organ during most of pregnancy, and placental weight is probably related to the level of hormonal exposure in utero (40) . Although we were able to retrieve information on placental weight for only about 30% of the case patients and control subjects, increasing placental weight was significantly associated (P for trend = .05) with an increasing risk of seminomas, in accordance with the view that seminoma is a hormone-related tumor.
In Sweden, as in other European countries, an increasing incidence of testicular cancer has been observed during the past 30 years (6) . The findings of this study may provide an explanation for a small portion of this increase, i.e., changes in fertility patterns (such as decreasing parity and increasing maternal age). Furthermore, increasing birth weights and improved survival of prematurely born infants of low birth weight-yielding individuals who are at high risk of developing testicular cancercould also influence the trend. However, the variables examined in this study are only blunt surrogate measures of underlying "true" causal factors that are yet to be found, possibly in the environment or as endogenous factors in the mother (23) .
In conclusion, our findings strengthen the hypothesis that intrauterine exposures may be instrumental in the etiology of testicular cancer. Moreover, the data of this study suggest that etiologic differences between the two main histologic types of testicular cancer may exist, although instability of the estimates because of power limitations hinders conclusive inference.
